SHMLF (SHL Telemedicine) Forward PE Ratio: 0.00 (As of Jul. 09, 2026)


SHMLF SHL Telemedicine Ltd SHMLF
52 GF Score
Price $4.84
GF Value $12.09
! 3 Warning Signs
View Full Analysis

What is SHL Telemedicine Forward PE Ratio?

SHL Telemedicine SHMLF 52 Forward PE Ratio is 0.00 as of Jul. 09, 2026. GuruFocus rates SHMLF with a GF Score™ of 52/100 and a GF Value™ of $12.09. The stock has 3 warning signs investors should review. Among 314 Healthcare Providers & Services companies, SHL Telemedicine ranks worse than 318471.02% on this metric.

SHL Telemedicine's Forward PE Ratio for today is 0.00.

SHL Telemedicine's PE Ratio without NRI for today is 0.00.

SHL Telemedicine's PE Ratio (TTM) for today is 0.00.


SHL Telemedicine  (OTCPK:SHMLF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


SHL Telemedicine Forward PE Ratio Related Terms


SHL Telemedicine Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for SHL Telemedicine's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SHL Telemedicine Forward PE Ratio Chart

SHL Telemedicine Annual Data
Trend
Forward PE Ratio

SHL Telemedicine Semi-Annual Data
Forward PE Ratio

SHMLF vs VEEV, BTSG, TEM: Forward PE Ratio Comparison

For the Health Information Services subindustry, SHL Telemedicine's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SHL Telemedicine Forward PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's Forward PE Ratio falls into.


SHMLF
52GF Score
SHL Telemedicine Ltd SHMLF
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SHL Telemedicine Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
SHL Telemedicine (SHMLF) has a Forward PE Ratio of 0.00 as of Jul. 09, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on SHL Telemedicine and its competitors. According to the industry distribution chart, SHL Telemedicine ranks #999999 out of 314 companies in the Healthcare Providers & Services industry.
Is SHL Telemedicine's Forward PE Ratio too high?
SHL Telemedicine's current Forward PE Ratio is 0.00. Based on the distribution chart, SHL Telemedicine ranks #999999 out of 314 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, SHL Telemedicine has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Forward PE Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #999999 out of 314 companies for Forward PE Ratio. This places SHL Telemedicine in the lower half of its industry. The industry median Forward PE Ratio is 18.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.31, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current Forward PE Ratio of 0.00. The stock's GF Value™ is $12.09, compared to a current price of $4.84 — trading 59.9% below its estimated fair value. The current Forward PE Ratio is 0.00. SHL Telemedicine's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current Forward PE Ratio is 0.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SHL Telemedicine (SHMLF) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of $4.84 is trading 59.9% below its estimated GF Value™ of $12.09.

Key valuation signals for SHMLF:

  • Forward PE Ratio: 0.00
  • GF Value™: $12.09 vs. price of $4.84 (59.9% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SHL Telemedicine Business Description

Other Exchanges 0QMX:UKSHLTN:Switzerland
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
52GF Score

Get the complete analysis for SHMLF

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.84
Price
$12.09
GF Value